Schedule 13G ownership disclosure
Definium Therapeutics Inc
COMMON STOCK · CUSIP: 24477V105
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 8,791,720.34 · Class: 6.5%
- Abigail P. Johnson
Shares: 8,791,720.34 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002739
- Form type
- SCHEDULE 13G
- Filer
- Mind Medicine (MindMed) Inc.
- CIK
- CIK 1813814
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership